# Utilization and Efficacy of Tenofovir DF in Adolescents With Chronic Hepatitis B Virus Infection

> **NCT02479880** · PHASE4 · TERMINATED · sponsor: **Gilead Sciences** · enrollment: 30 (actual)

## Conditions studied

- Hepatitis B

## Interventions

- **DRUG:** Tenofovir DF
- **RADIATION:** DEXA Scan

## Key facts

- **NCT ID:** NCT02479880
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-07-03
- **Primary completion:** 2018-02-28
- **Final completion:** 2018-04-11
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02479880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02479880, "Utilization and Efficacy of Tenofovir DF in Adolescents With Chronic Hepatitis B Virus Infection". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02479880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*